Estimate the Spectrum and Prescription Pattern in Patients with Myocardial Infarction, Angina, Congestive Cardiac Failure at a Tertiary Care Hospital- Retrospective Study

Ramanath, K. V. and Emami, Niloufar and Lashani, Alireza (2022) Estimate the Spectrum and Prescription Pattern in Patients with Myocardial Infarction, Angina, Congestive Cardiac Failure at a Tertiary Care Hospital- Retrospective Study. International Journal of Biochemistry Research & Review, 31 (3). pp. 1-11. ISSN 2231-086X

[thumbnail of 740-Article Text-1433-1-10-20221010.pdf] Text
740-Article Text-1433-1-10-20221010.pdf - Published Version

Download (317kB)

Abstract

Introduction: Analysis of the prescription patterns is essential to improve rational prescribing in cardiac patients to decrease the risk associated with cardiovascular drugs & also to reduce morbidity and mortality. However, this type of study is progressively more important because of a boost in marketing of new medicines, variations in the prescribing and consumption of drugs, growing concern about delayed adverse effects, cost of drugs, and volume of prescription provokes us to carry out this study.

Objectives: To evaluate cardiovascular disease (Myocardial Infarction (MI), ANGINA, and Congestive Cardiac Failure (CCF) drugs prescribing pattern & its cost.

Methods: This study is a Retrospective case study carried out for a period of 6months at Sagar Hospitals, Bangalore, by collecting the required data in a structured questionnaire.

Results: Out of 250 patient cases observed, patients aged 60-69 were 31.6%, followed by 50-59 (26.8%) are more prone to CAD & males were more when compared to females. The study showed the highest number of patients suffering from Angina and the second highest in MI, and few patients have been diagnosed with CCF.

Conclusion: This study showed that Coronary artery disease was managed by antiplatelets, antihypertensives, statins, and diuretics;

Angina has the highest diagnosis rate under this study. However, the antianginal drug class does not practice well. However, these studies also show the path for the pharmacist's role in promoting rational drug promotion in cardiac disease management.

Item Type: Article
Subjects: European Repository > Biological Science
Depositing User: Managing Editor
Date Deposited: 28 Dec 2022 04:48
Last Modified: 27 Feb 2024 03:54
URI: http://go7publish.com/id/eprint/546

Actions (login required)

View Item
View Item